Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Immune Environment in Glioblastoma (Feb 2023)
    • Korsmeyer Award 25th Anniversary Collection (Jan 2023)
    • Aging (Jul 2022)
    • Next-Generation Sequencing in Medicine (Jun 2022)
    • New Therapeutic Targets in Cardiovascular Diseases (Mar 2022)
    • Immunometabolism (Jan 2022)
    • Circadian Rhythm (Oct 2021)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Research letters
    • Letters to the editor
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Research letters
  • Letters to the editor
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
Restoration of LDL receptor function in cells from patients with autosomal recessive hypercholesterolemia by retroviral expression of ARH1
Emily R. Eden, … , Rossitza P. Naoumova, Anne K. Soutar
Emily R. Eden, … , Rossitza P. Naoumova, Anne K. Soutar
Published December 1, 2002
Citation Information: J Clin Invest. 2002;110(11):1695-1702. https://doi.org/10.1172/JCI16445.
View: Text | PDF
Article Cardiology

Restoration of LDL receptor function in cells from patients with autosomal recessive hypercholesterolemia by retroviral expression of ARH1

  • Text
  • PDF
Abstract

Research Article

Authors

Emily R. Eden, Dilipkumar D. Patel, Xi-Ming Sun, Jemima J. Burden, Michael Themis, Matthew Edwards, Philip Lee, Clare Neuwirth, Rossitza P. Naoumova, Anne K. Soutar

×

Figure 4

Options: View larger image (or click on image) Download as PowerPoint
Degradation of 125I-labeled LDL by cultured skin fibroblasts and EBV- ly...
Degradation of 125I-labeled LDL by cultured skin fibroblasts and EBV- lymphocytes from individuals in family 1. Cells were preincubated for 16 hours in medium containing LPDS and then for 4 hours with 125I-labeled LDL. Saturable degradation of LDL was determined as the difference in the amount of trichloroacetic acid–soluble (TCA-soluble), non-iodide radioactivity in the medium of cells incubated in the presence and absence of an excess of unlabeled LDL (1 mg/ml); values are the mean of duplicate dishes. Nonsaturable degradation of LDL by normal cells was always less than 5% of the total. Data shown are representative of at least two separate experiments. (a) Cultured skin fibroblasts from the proband in family 1 (ARH–/–), and from a normolipemic control (ARH+/+). (b) EBV-lymphocytes from the proband in family 1 (ARH–/–), her heterozygous sibling (ARH+/–), and a sibling who does not carry the mutant allele (ARH+/+).

Copyright © 2023 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts